Modifying the Course of Multiple Sclerosis: The Growing Treatment Armamentarium
In examining the likelihood of adherence to various medications for multiple sclerosis (MS), Stephen Krieger, MD, believes most patients prefer oral therapies over injectable ones.
Although there are a wide variety of treatment options available for patients with attention deficit hyperactivity disorder, methods for finding the proper course of treatment are still under development.
In 2 recent clinical trials, a treatment for young patients diagnosed with attention deficit hyperactivity disorder reportedly demonstrated benefit over another currently used ADHD medication.
A better understanding of the needs of patients with advanced multimorbidity may offer insights into how to improve care, according to research published online May 28 in BMJ Supportive & Palliative Care.
Following chronic, traumatic spinal cord injury (SCI), some bone biomarkers undergo noticeable changes, according to a study published in the July 1 issue of The Spine Journal.
Physicians need to be aware of the ramifications of providing financial assistance to patients, according to an article published July 8 in Medical Economics.
Providing additional insight into mental illnesses such as schizophrenia and bipolar disorder, recent research has found neurological operations at rest are similar to those seen during active tasks.
Physicians are more likely to register to be organ donors than the general public, according to a research letter published in the July 16 issue of the Journal of the American Medical Association.
Amyotrophic lateral sclerosis (ALS) may be delayed or prevented with the consumption of foods high in ω-3 polyunsaturated fatty acids (PUFAs), according to a study published in the July 16 issue of JAMA Neurology.
In an effort to help patients diagnosed with mild-to-moderate Alzheimer’s disease, drug manufacturer Roche announced the results of a pair of clinical studies on its investigational medication, crenezumab.